The pharmaceutical industry has long criticized pricing rules, saying they can dramatically cut into revenue and reduce incentives for new drug development.

China and the United States announced a truce in their trade war on Monday after talks in Geneva that will roll back the bulk of tariffs and other countermeasures by Wednesday.

It’s unclear how quickly Americans will see lower prices and what authority the US government has to direct drug pricing in other countries.